DiscoverIPO

MED-X, Inc.

expected
Not yet set
status
Filed with SEC
Industry
Agricultural Chemicals
Headquarters
United States
Incorporated in
NV
Underwriters (from filing)
EF Hutton, division of Benchmark Investments, LLC

Overview

— AI-generated from the filing, see note below

Business overview

Med-X, Inc. is a Nevada corporation incorporated in February 2014. Initially, it aimed to engage in publishing cannabis-related content, wholesaling cannabis, supplying agricultural products, and developing medicinal supplements. Currently, the company focuses on supplying environmentally friendly health and wellness products through divisions such as Nature-Cide, Thermal-Aid, Malibu Brands, and Advertising. Additionally, it operates the MJT Network, an online media platform about the cannabis industry. Due to regulatory constraints, operations related to cannabis have not fully materialized, yet the company continues to explore opportunities in health and wellness and pest control services.

Revenue model

The company generates revenue primarily through the sales of its products in four divisions: Nature-Cide, Thermal-Aid, Malibu Brands, and Advertising. Nature-Cide and Thermal-Aid are significant contributors to revenue, making up a majority of sales from 2020 to 2021. The MJT Network also contributes to revenue through advertising.

Last FY net loss
$18M

Competitive strengths

  • Focus on environmentally friendly health and wellness products
  • Active engagement in cannabis industry media through MJT Network
  • Diverse product offerings across different sectors
  • Strong partnerships with distribution outlets

Risk factors

  • Limited operating history
  • Accumulated deficit raising doubt about the ability to continue as a going concern
  • Possible inability to raise additional needed capital
  • Adverse impacts from COVID-19 pandemic on operations and supply chain

Use of proceeds

Not disclosed in the provided filing text.

This summary is generated automatically from the company's own filing and may contain errors or omissions. It is a reading aid, not a substitute for the filing itself, and it is not advice.

IPO details

Underwriters on the deal include EF Hutton, division of Benchmark Investments, LLC. MED-X, Inc. is headquartered in United States and incorporated in NV. It is classified under Agricultural Chemicals.

Related IPO lists

Other IPOs DiscoverIPO tracks that share a sector, market, or underwriter with MED-X, Inc..

Embed this company

Drop a live deal card into your own site — works in WordPress, Ghost, Notion, Webflow, and any self-hosted page that allows an <iframe>. It does not work in Substack or in an emailed newsletter — no email client, and Substack itself, supports arbitrary iframes. For those, use the share image or the attribution text below instead.

Iframe — WordPress / Ghost / Notion / Webflow

<iframe src="https://www.discoveripo.com/embed/med-x" width="100%" height="300" style="border:0;max-width:560px" loading="lazy" title="MED-X, Inc. — DiscoverIPO"></iframe>

Dark by default. For a light background, use https://www.discoveripo.com/embed/med-x?theme=light as the src instead.

Share image — Substack, email, anywhere

https://www.discoveripo.com/ipo/med-x/opengraph-image

Attribution text

MED-X, Inc. IPO details — tracked by DiscoverIPO: https://www.discoveripo.com/ipo/med-x?utm_source=embed&utm_medium=text&utm_campaign=med-x

Track this IPO

Get emailed when MED-X, Inc.'s terms, price, or expected date change — no weekly noise, just this company.

Where this data comes from

Registration statement filed with the U.S. Securities and Exchange Commission. Retrieved Oct 15, 2026.

View the original filing on SEC EDGAR →

Not investment advice. DiscoverIPO is an informational database. Nothing here is a recommendation to buy or sell any security, and no content should be relied on as financial advice. All figures come from public securities-regulator filings, may be incomplete or out of date, and should be verified against the original source before you act on them.

We use analytics and marketing cookies to understand traffic and improve the site. Cookie Policy